Danish pharma company Novo Nordisk is preparing for an early launch of its weight-loss drug Wegovy in India.The decision to launch early is in order to compete with Eli Lilly's weight-loss drug, Mounjaro.The accelerated plan is to take advantage of India's growing market for weight-loss solutions.The demand for weight-loss drugs like Wegovy and Mounjaro is rising globally.